The news followed an investigation by POLITICO's E&E News into climate-friendly inhalers and how drug giants are developing ...

Massachusetts families are still struggling to find alternatives almost a year after GlaxoSmithKline canceled a widely ...

Asthma hospitalisations among Māori have decreased, according to a new study, but experts warn there is still a long way to ...

when used as a reliever inhaler, the ICS-formoterol relieves the acute symptoms while also addressing the underlying ...

Quintupling the ICS dose in children age 5 to 11 who lose asthma control may worsen outcomes in those with a higher socio-economic status.

Despite the positive findings, the research reveals a persistent two-and-a-half-fold disparity in asthma hospitalisation rates between Māori and non-Māori, indicating that while progress has been made ...

The cost of medication to treat asthma, the chronic lung disease, is stopping one in six US adults from taking their medication as it has been prescribed, researchers warned Monday. At such a critical ...

In recent weeks there has been a buzz around a new treatment breakthrough: benralizumab, which in a study published in the ...

The first new treatment for asthma in 50 years has been developed with “dramatic effects” for sufferers, Luke O’Neill has ...

Winter can be a challenging season for those living with asthma, as the cold air, indoor allergens, and seasonal illnesses ...

A senior woman uses her inhaler. New research has found that one in six US adults are stopped from taking their asthma medication as it has been prescribed due to its cost (Getty Images/iStock ...

Major companies in the dry powder inhaler market are focusing on innovation, developing products with muscarinic antagonists for the treatment of chronic obstructive pulmonary disease (COPD), and ...